0
Passer au contenu
Elyan
Accueil
Qui sommes nous ?
Pourquoi choisir Elyan Partners ?
Notre Équipe
Edmond de Rothschild Private Equity
Engagements
News
Réclamation
Home
About us
Why work with us ?
Our Team
Edmond de Rothschild Private Equity
Commitments
News
Claim
FR
EN
Elyan
Accueil
Qui sommes nous ?
Pourquoi choisir Elyan Partners ?
Notre Équipe
Edmond de Rothschild Private Equity
Engagements
News
Réclamation
Home
About us
Why work with us ?
Our Team
Edmond de Rothschild Private Equity
Commitments
News
Claim
FR
EN
Accueil
Qui sommes nous ?
Pourquoi choisir Elyan Partners ?
Notre Équipe
Edmond de Rothschild Private Equity
Engagements
News
Réclamation
Home
About us
Why work with us ?
Our Team
Edmond de Rothschild Private Equity
Commitments
News
Claim
FR
EN
Oncodesign Services, a major European CRO in preclinical Drug Discovery, majority-owned by ERES IV SLP, has acquired ZoBio. Nov Santé Actions Non Cotées, managed by Eurazeo, enters the Group’s capital
Claire Russel 23/01/2024 Claire Russel 23/01/2024

Oncodesign Services, a major European CRO in preclinical Drug Discovery, majority-owned by ERES IV SLP, has acquired ZoBio. Nov Santé Actions Non Cotées, managed by Eurazeo, enters the Group’s capital

Lire la suite
ELYAN enters into exclusive negotiation to acquire a majority stake in STORDATA, the data management and security expert
Vincent Manes 10/01/2024 Vincent Manes 10/01/2024

ELYAN enters into exclusive negotiation to acquire a majority stake in STORDATA, the data management and security expert

Lire la suite
ERES IV, managed by Edmond de Rothschild Private Equity (France) and advised by Elyan, invests $30m in Decks & Docks, a US B2B distributor of marine construction and outdoor living supplies
Claire Russel 12/10/2023 Claire Russel 12/10/2023

ERES IV, managed by Edmond de Rothschild Private Equity (France) and advised by Elyan, invests $30m in Decks & Docks, a US B2B distributor of marine construction and outdoor living supplies

Lire la suite
Tikamoon partners with a new shareholder to finance an ambitious growth strategy
Claire Russel 29/06/2023 Claire Russel 29/06/2023

Tikamoon partners with a new shareholder to finance an ambitious growth strategy

Lire la suite
Edmond de Rothschild Private Equity and Elyan Partners raise over €500m for ERES IV - the fund will invest in midcap companies in Europe and North America
Maxence de Vienne 15/03/2023 Maxence de Vienne 15/03/2023

Edmond de Rothschild Private Equity and Elyan Partners raise over €500m for ERES IV - the fund will invest in midcap companies in Europe and North America

Lire la suite
ERES IV, advised by ELYAN PARTNERS, acquires a majority stake in ONCODESIGN SERVICES and will file a simplified tender offer on the company's remaining shares
Vincent Manes 26/10/2022 Vincent Manes 26/10/2022

ERES IV, advised by ELYAN PARTNERS, acquires a majority stake in ONCODESIGN SERVICES and will file a simplified tender offer on the company's remaining shares

Lire la suite
ELYAN PARTNERS enters into exclusive negotiations for the acquisition of a majority stake in the capital of ONCODESIGN (service) followed by the filing of a simplified takeover offer
Maxence de Vienne 01/07/2022 Maxence de Vienne 01/07/2022

ELYAN PARTNERS enters into exclusive negotiations for the acquisition of a majority stake in the capital of ONCODESIGN (service) followed by the filing of a simplified takeover offer

Lire la suite
ERES invests in HungerRush
Vincent Manes 15/06/2022 Vincent Manes 15/06/2022

ERES invests in HungerRush

Lire la suite
ERES IV invests in Freightwise
Albane Streichenberger 05/05/2022 Albane Streichenberger 05/05/2022

ERES IV invests in Freightwise

Lire la suite
True Wind Capital and Elyan Partners Make Strategic Growth Investment in Envoy Global
JF Felix 24/01/2022 JF Felix 24/01/2022

True Wind Capital and Elyan Partners Make Strategic Growth Investment in Envoy Global

Lire la suite
Reprise de la DNVB française Tikamoon à ADEO par ses dirigeants, avec le soutien d’ERES
JF Felix 07/06/2021 JF Felix 07/06/2021

Reprise de la DNVB française Tikamoon à ADEO par ses dirigeants, avec le soutien d’ERES

Lire la suite

CONTACT

25-27 Place de La Madeleine
75008 Paris
- France
contact@elyan.com

Plan d’accès

Réclamation

EN SAVOIR PLUS

Qui sommes-nous ?
Notre Équipe
Pourquoi travailler avec nous ?
EdR Private Equity
Nos Engagements
News

 
 

Elyan Partners SAS is independant and a member of the Edmond de Rothshild Private Equity Partnership.
Elyan Partners SAS is registered with ORIAS in the Financial Investment Advisor category under number 21006631.

Dénomination sociale : Elyan Partners SAS
Société par Actions Simplifiée au capital de 1000 euros
RCS Paris n°B 900 318 593
Siège social : 25-27 Place de La Madeleine, 75008 Paris, France
contact@elyan.com
SIREN n°900 318 593 - Code NAF: 6619 B
Orias n°21006631 – TVA intracommunautaire n°FR06900318593

 

CONTACT

25-27 Place de La Madeleine
75008 Paris - France
contact@elyan.com

Acces

Claim

MORE ABOUT US

About us
Our Team
Why work with us ?
EdR Private Equity
Our Commitments
News

 
 

Elyan Partners SAS is controlled by its management team and is a member of the Edmond de Rothshild Private Equity Partnership.
Elyan Partners SAS is registered with ORIAS in the Financial Investment Advisor category under number 21006631.

Company name: Elyan Partners SAS
Société par Actions Simplifiée with a capital of 1000 euros
RCS Paris n°B 900 318 593
Head office: 25-27 Place de La Madeleine - 75008 Paris, France
contact@elyan.com
SIREN n°900 318 593 - NAF: 6619 B
Orias n°21006631 – VAT n°FR06900318593